Letter to the Editor

‘Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation’ by Ali et al. – reassess the evidence, shall we?

Saiz-Rodríguez, Miriam^a; Zubiaur, Pablo^b; Abad-Santos, Francisco^b,c

^aResearch Unit, Fundación Burgos por la Investigación de la Salud (FBIS), Hospital Universitario de Burgos, Burgos

^bClinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria La Princesa (IP), Universidad Autónoma de Madrid (UAM)

^cCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain

Received 1 February 2023 Accepted 4 February 2023.

Correspondence to Miriam Saiz-Rodríguez, PhD, Research Unit, Fundación Burgos por la Investigación de la Salud (FBIS), Hospital Universitario de Burgos, Burgos 09006, Spain, Tel: +34 947256533; e-mail: [email protected]

Pharmacogenetics and Genomics 33(4):p 88-89, June 2023. | DOI: 10.1097/FPC.0000000000000496

Secondary Logo

Journal Logo

‘Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation’ by Ali et al. – reassess the evidence, shall we?

Full Text Access for Subscribers:

Institutional Users

Not a Subscriber?

Article Level Metrics

Related Links

Related Videos

‘Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation’ by Ali et al. – reassess the evidence, shall we? : Pharmacogenetics and Genomics

Full Text Access for Subscribers:

Individual Subscribers

Institutional Users

Not a Subscriber?